Jones Financial Companies
IRWD icon

Jones Financial Companies’s Ironwood Pharmaceuticals IRWD Stock Holding History

Jones Financial Companies’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.1K Buy
1,993
+310
+18% +$1.27K ﹤0.01% 3768
2025
Q4 		$5.67K Buy
+1,683
New +$4.37K ﹤0.01% 3449

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jones Financial Companies's IRWD Position: Q1 2026 in Review

Jones Financial Companies increased its Ironwood Pharmaceuticals (IRWD) stake by 18% in Q1 2026, buying an estimated $1.27K and bringing the position to 1,993 shares worth $6.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3768.

Jones Financial Companies first reported a position in IRWD in Q4 2025 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Jones Financial Companies held 1,993 shares of Ironwood Pharmaceuticals worth $6.1K as of Q1 2026.
  • Jones Financial Companies bought 310 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $1.27K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3768 holding.
  • Jones Financial Companies first reported a position in Ironwood Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.